Wikidata

(Q80442324)

English

Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis

scientific article published on 01 November 2007

In more languages
default for all languages
No label defined

No description defined

Statements

title
Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18173917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18173917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q80442324&oldid=2245534535"